Inventor · disambiguated record
Mark S. Fineman
Also filed as: FINEMAN MARK · FINEMAN MARK S
27 granted patents·12 pending applications·352 citations·filing 2003–2024
97Inventor score
Files withELCELYX THERAPEUTICS INC11AMYLIN PHARMACEUTICALS LLC7BARON ALAIN D5ANJI PHARMA US LLC4ALKERMES INC3
Top patents by PatentIndex Score
39 records- 0197US9211263B2Compositions and methods of treating metabolic disordersELCELYX THERAPEUTICS INC·Filed 2013·Granted Dec 15, 2015·24 cites·8 claims
- 0297US7563871B2Polymer-based sustained release deviceALKERMES INC·Filed 2006·Granted Jul 21, 2009·79 cites·20 claims
- 0396US10610500B2Chemosensory receptor ligand-based therapiesANJI PHARMA US LLC·Filed 2018·Granted Apr 7, 2020·8 cites·41 claims
- 0495US10028923B2Biguanide compositions and methods of treating metabolic disordersELCELYX THERAPEUTICS INC·Filed 2016·Granted Jul 24, 2018·9 cites·26 claims
- 0595US9962344B2Chemosensory receptor ligand-based therapiesELCELYX THERAPEUTICS INC·Filed 2016·Granted May 8, 2018·14 cites·24 claims
- 0695US9481642B2Biguanide compositions and methods of treating metabolic disordersELCELYX THERAPEUTICS INC·Filed 2014·Granted Nov 1, 2016·14 cites·25 claims
- 0795US9463170B2Chemosensory receptor ligand-based therapiesELCELYX THERAPEUTICS INC·Filed 2015·Granted Oct 11, 2016·15 cites·35 claims
- 0895US8796338B2Biguanide compositions and methods of treating metabolic disordersBARON ALAIN D·Filed 2012·Granted Aug 5, 2014·27 cites·14 claims
- 0994US10159658B2Compositions comprising statins, biguanides and further agents for reducing cardiometabolic riskELCELYX THERAPEUTICS INC·Filed 2017·Granted Dec 25, 2018·8 cites·29 claims
- 1094US9770422B2Compositions and methods for treating metabolic disordersELCELYX THERAPEUTICS INC·Filed 2015·Granted Sep 26, 2017·7 cites·23 claims
- 1193US10603291B2Compositions and methods for treating metabolic disordersANJI PHARMA US LLC·Filed 2017·Granted Mar 31, 2020·5 cites·30 claims
- 1293US9050292B2Chemosensory receptor ligand-based therapiesBARON ALAIN D·Filed 2012·Granted Jun 9, 2015·24 cites·25 claims
- 1393US8329648B2Methods for treating diabetes and reducing body weightFINEMAN MARK·Filed 2011·Granted Dec 11, 2012·38 cites·20 claims
- 1492US10668031B2Biguanide compositions and methods of treating metabolic disordersANJI PHARMA US LLC·Filed 2018·Granted Jun 2, 2020·6 cites·24 claims
- 1592US10154972B2Biguanide compositions and methods of treating metabolic disordersELCELYX THERAPEUTICS INC·Filed 2016·Granted Dec 18, 2018·10 cites·27 claims
- 1692US9572784B2Compositions comprising statins, biguanides and further agents for reducing cardiometabolic riskELCELYX THERAPEUTICS INC·Filed 2013·Granted Feb 21, 2017·7 cites·23 claims
- 1792US8906851B2Method for treating diabetesAMYLIN PHARMACEUTICALS LLC·Filed 2012·Granted Dec 9, 2014·17 cites·8 claims
- 1892US8293871B2Poly(lactide-co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugarWRIGHT STEVEN G·Filed 2005·Granted Oct 23, 2012·18 cites·3 claims
- 1991US9480663B2Biguanide compositions and methods of treating metabolic disordersBARON ALAIN D·Filed 2012·Granted Nov 1, 2016·8 cites·27 claims
- 2088US10201511B2Compositions and methods for treating metabolic disordersELCELYX THERAPEUTICS INC·Filed 2013·Granted Feb 12, 2019·8 cites·39 claims
- 2183US11065215B2Biguanide compositions and methods of treating metabolic disordersANJI PHARMA US LLC·Filed 2018·Granted Jul 20, 2021·3 cites·23 claims
- 2278US9238076B2Polymer-based sustained release deviceALKERMES PHARMA IRELAND LTD·Filed 2013·Granted Jan 19, 2016·2 cites·6 claims
- 2377US2025000804A1Compositions and methods for treating metabolic disordersANJI PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2470US2020222509A1Methods for treating diabetes and reducing body weightAMYLIN PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 2568US2009247463A1Polymer-based sustained release deviceALKERMES INC·Filed 2009·Application pending·0 cites
- 2667US9486463B2Chemosensory receptor ligand-based therapiesBARON ALAIN D·Filed 2011·Granted Nov 8, 2016·1 cites·33 claims
- 2765US9034819B2Method of lowering cholesterol and triglycerides by administering exendinsAMYLIN PHARMACEUTICALS LLC·Filed 2013·Granted May 19, 2015·0 cites·6 claims
- 2865US2015150948A1Methods for treating diabetes and reducing body weightAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 2964US2018333468A1Methods for treating diabetes and reducing body weightAMYLIN PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 3063US2011263496A1Exendins to lower cholesterol and triglyceridesAMYLIN PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 3163US2008119569A1Polymer-based sustained release deviceALKERMES INC·Filed 2007·Application pending·0 cites
- 3262US9884092B2Methods for treating diabetes and reducing body weightAMYLIN PHARMACEUTICALS LLC·Filed 2016·Granted Feb 6, 2018·0 cites·22 claims
- 3361US2009239796A1Methods for treating diabetes and reducing body weightAMYLIN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3458US11759441B2Biguanide compositions and methods of treating metabolic disordersANJI PHARMACEUTICALS INC·Filed 2021·Granted Sep 19, 2023·0 cites·13 claims
- 3557US2020093750A1Compositions and methods for treating metabolic disordersBARON ALAIN D·Filed 2019·Application pending·0 cites
- 3655US2015238568A1Exendins to lower cholesterol and triglyceridesAMYLIN PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 3754US2014193498A1Compositions and Methods for Treating Metabolic DisordersELCELYX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3852US11974971B2Compositions and methods for treating metabolic disordersANJI PHARMACEUTICALS INC·Filed 2019·Granted May 7, 2024·0 cites·7 claims
- 3945US2003130177A1Use of amylin agonists to modulate triglyceridesFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark S. Fineman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →